A dealership's rating is based on all of their reviews, with more weight given to recent reviews. Includes reviews of Shaker's Family Hyundai from DealerRater. Want to share your experience with this ...
Two years after AstraZeneca splashed out $1 billion upfront for rights to Daiichi Sankyo's TROP2-targeting antibody-drug conjugate DS-1062, the drug has generate promising results in advanced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results